Brand Name(s): Risperdal
CAS nº: 106266-06-2
(ris per’ i done)
About Risperidone
This new site is dedicated exclusively to risperidone.
It offers you the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about risperidone, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total risperidone experience!
Why is this medication prescribed?
Risperidone is an atypical antipsychotic medication. It is most often used to treat delusional psychosis (including schizophrenia).
This medication is also used to treat some forms of bipolar disorder and psychotic depression.
Risperidone works by changing the effects of chemicals in the brain. Some of the brand names of risperidone is the US are Belivon®, Rispen®, Risperdal®.
Latest News
A Preliminary Attempt to Personalize Risperidone Dosing Using Drug–Drug Interactions and Genetics: Part I
BACKGROUND: Personalized prescription is described even in lay journals, but there has been no...
[more]Acadia Pharma To Present Data From Its Pimavanserin Phase II Schizophrenia Co-therapy Trial
Tuesday morning, biopharmaceutical company Acadia Pharmaceuticals, Inc. said that it would present...
[more]Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an...
[more]Teva Trying to Assert Its Rights
A reader recently e-mailed me about an interesting citizen petition that Teva (TEVA) filed last...
[more]Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
BACKGROUND: Aggressive challenging behaviour is frequently reported in adults with intellectual...
[more]